Skip to content

Research at St Andrews

Medication adherence, utilisation of healthcare services and mortality of patients with epilepsy on opiate replacement therapy: a retrospective cohort study

Research output: Contribution to journalArticlepeer-review

Open Access Status

  • Embargoed (until 20/02/22)

Author(s)

Amber Askarieh, Ian Morrison, Kevin Ross, Colin McCowan, Keith Matthews, Brian Kidd, Craig A. Heath

School/Research organisations

Abstract

Introduction: Substance misuse is not uncommonly recognized in people with epilepsy (PWE). Mortality is significantly greater in those with comorbid substance misuse, but it remains unclear whether epilepsy care and management contribute to this. This cohort study aimed to compare the rates of mortality in PWE receiving opiate replacement therapy (ORT) and PWE alone, as well as evaluate their medication adherence, levels of engagement with epilepsy services as currently delivered, and utilization of unscheduled hospital care.

Material and methods: A 5-year historical cohort for PWE was identified and manually validated using electronic patient records registered with NHS Tayside. Overall incidence rates for mortality and contact with emergency health care services were calculated for PWE receiving ORT and PWE alone. Engagement with outpatient epilepsy services was also noted. Adherence to antiepileptic drugs (AEDs) was expressed in terms of medication possession ratio (MPR).

Results: Of the 1297 PWE attending a tertiary care epilepsy service, 68 (5.3%) PWE were receiving ORT. The mortality rate was significantly greater in PWE on ORT in comparison to PWE only (7.4% vs 1.7 %; P < 0.05; relative risk of death: 4.34, 95% CI 1.19–15.7), as well as the incidence of emergency healthcare services contact being higher (24.5% vs 17.7%; P < 0.05; incidence rate ratio: 1.39, 95% CI: 1.12–1.71). Poor adherence to AEDs was also more common in PWE on ORT (28.4% vs 23.5%; P = 0.02), as well as failure to engage with elective outpatient services (8.4% vs 3.0%; P < 0.05; rate ratio 2.77, 95% CI: 1.86–4.1).

Conclusion: People with epilepsy on ORT are less likely to engage with elective epilepsy services as currently delivered or take AEDs as prescribed despite most of these patients having daily attendance at a community pharmacist. This may contribute to the significantly increased rates of mortality and unscheduled hospital care. Clinicians and policymakers should consider service redesign to meet the demands of this high-risk population in an attempt to reduce mortality and morbidity
Close

Details

Original languageEnglish
Article number107829
Number of pages4
JournalEpilepsy & Behaviour
Volume117
Early online date20 Feb 2021
DOIs
Publication statusPublished - Apr 2021

    Research areas

  • Epilepsy, Opiate, Methadone, Mortality, Adherence, Antiepileptic drugs

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

    Flook, M., Jackson, C., Vasileiou, E., Simpson, C. R., Muckian, M. D., Agrawal, U., McCowan, C., Jia, Y., Murray, J. L. K., Ritchie, L. D., Robertson, C., Stock, S. J., Wang, X., Woolhouse, M. E. J., Sheikh, A. & Stagg, H. R., 12 Apr 2021, In: BMC Infectious Diseases. 21, 23 p., 342.

    Research output: Contribution to journalArticlepeer-review

  2. Changes over time in the management of long-term conditions in primary health-care for adults with intellectual disabilities, and the health-care inequalities gap

    Hughes-McCormack, L., Greenlaw, N., McSkimming, P., McCowan, C., Ross, K., Allan, L., Henderson, A., Melville, C., Morrison, J. & Cooper, S-A., Mar 2021, In: Journal of Applied Research in Intellectual Disabilities. 34, 2, p. 634-647

    Research output: Contribution to journalArticlepeer-review

  3. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

    Mulholland, R. H., Vasileiou, E., Simpson, C. R., Ritchie, L. D., Agrawal, U., Woolhouse, M., Murray, J. L. K., Stagg, H. R., Docherty, A. B., McCowan, C., Wood, R., Stock, S. J. & Sheikh, A., 29 Jan 2021, (Accepted/In press) In: International Journal of Epidemiology.

    Research output: Contribution to journalArticlepeer-review

  4. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

    Sullivan, F. M., Mair, F. S., Anderson, W., Armory, P., Briggs, A., Chew, C., Dorward, A., Haughney, J., Hogarth, F., Kendrick, D., Littleford, R., Mcconnachie, A., McCowan, C., Mcmeekin, N., Patel, M., Rauchhaus, P., Ritchie, L., Robertson, C., Robertson, J., Robles-Zurita, J. & 8 others, Sarvesvaran, J., Sewell, H., Sproule, M., Taylor, T., Tello, A., Treweek, S., Vedhara, K. & Schembri, S., 1 Jan 2021, In: European Respiratory Journal. 57, 1, 11 p., 2000670.

    Research output: Contribution to journalArticlepeer-review

  5. Protocol for the development of the Wales multimorbidity e-Cohort (WMC): data sources and methods to construct a population-based research platform to investigate multi-morbidity

    Lyons, J., Akbari, A., Agrawal, U., Harper, G., Azcoaga-Lorenzo, A., Bailey, R., Rafferty, J., Watkins, A., Fry, R., McCowan, C., Dezateux, C., Robson, J. P., Peek, N., Holmes, C., Denaxas, S., Owen, R., Abrams, K. R., John, A., O'Reilly, D., Richardson, S. & 9 others, Hall, M., Gale, C. P., Davies, J., Davies, C., Cross, L., Gallacher, J., Chess, J., Brookes, A. J. & Lyons, R. A., Jan 2021, In: BMJ Open. 11, 1, 8 p., e047101.

    Research output: Contribution to journalArticlepeer-review

ID: 272563008

Top